Your browser doesn't support javascript.
loading
Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Imai, Hisao; Wasamoto, Satoshi; Tsuda, Takeshi; Nagai, Yoshiaki; Kishikawa, Takayuki; Masubuchi, Ken; Osaki, Takashi; Miura, Yosuke; Umeda, Yukihiro; Ono, Akihiro; Minemura, Hiroyuki; Yamada, Yutaka; Nakagawa, Junichi; Kozu, Yuki; Taniguchi, Hirokazu; Ohta, Hiromitsu; Kasai, Takashi; Kaira, Kyoichi; Kagamu, Hiroshi.
Affiliation
  • Imai H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.
  • Wasamoto S; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan.
  • Tsuda T; Division of Respiratory Medicine, Saku Central Hospital Advanced Care Center, Saku, Nagano, Japan.
  • Nagai Y; Division of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama, Toayama, Japan.
  • Kishikawa T; Department of Respiratory Medicine, Jichi Medical University, Saitama Medical Center, Saitama, Saitama, Japan.
  • Masubuchi K; Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Osaki T; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota, Gunma, Japan.
  • Miura Y; Division of Respiratory Medicine, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan.
  • Umeda Y; Division of Allergy and Respiratory Medicine, Integrative Centre of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
  • Ono A; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji, Fukui, Japan.
  • Minemura H; Division of Internal Medicine, Kiryu Kosei General Hospital, Kiryu, Gunma, Japan.
  • Yamada Y; Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Fukushima, Japan.
  • Nakagawa J; Division of Respiratory Medicine, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan.
  • Kozu Y; Division of Respiratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan.
  • Taniguchi H; Division of Respiratory Medicine, Saku Central Hospital Advanced Care Center, Saku, Nagano, Japan.
  • Ohta H; Division of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama, Toayama, Japan.
  • Kasai T; Department of Respiratory Medicine, Jichi Medical University, Saitama Medical Center, Saitama, Saitama, Japan.
  • Kaira K; Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
  • Kagamu H; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.
Thorac Cancer ; 14(25): 2567-2578, 2023 09.
Article in En | MEDLINE | ID: mdl-37469246
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thorac Cancer Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thorac Cancer Year: 2023 Document type: Article Affiliation country: Country of publication: